Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · IEX Real-Time Price · USD
9.80
-0.14 (-1.41%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Neumora Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$23.80
Upside
+142.86%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $31 | Buy | Reiterates | $31 | +216.33% | Mar 28, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $20 → $22 | Buy | Maintains | $20 → $22 | +124.49% | Mar 18, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $24 → $31 | Buy | Maintains | $24 → $31 | +216.33% | Mar 8, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $21 → $20 | Buy | Maintains | $21 → $20 | +104.08% | Nov 8, 2023 |
| JP Morgan | JP Morgan | Buy Initiates $21 | Buy | Initiates | $21 | +114.29% | Oct 10, 2023 |
| B of A Securities | B of A Securities | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +83.67% | Oct 10, 2023 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 10, 2023 |
| Guggenheim | Guggenheim | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +124.49% | Oct 10, 2023 |
| RBC Capital | RBC Capital | Buy Initiates $24 | Buy | Initiates | $24 | +144.90% | Oct 10, 2023 |
| Stifel | Stifel | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +165.31% | Oct 10, 2023 |